Lifestance Health Group Inc (LFST)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 4:15 PM ET
Lifestance Health Group Inc (LFST) Statistics
Lifestance Health Group (LFST) has a market cap of $5.35B and an enterprise value of $5.39B. Revenue grew 22.62% over the last 12 months from the 12 months before. Its return on invested capital of 4.57% compares with a 12.96% median across 10 similar companies.
Total Valuation
Enterprise value is 0.69% above the market cap, as debt exceeds cash.
| Market Cap | $5.35B |
|---|---|
| Enterprise Value | $5.39B |
| Latest price (Nov 17, 2026) | $14.17 |
Key Dates
| Last Earnings Date | Nov 5, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.2x and 3.6x.
| P/E Ratio | 50.9x |
|---|---|
| Forward P/E | 80.9x |
| P/S Ratio | 3.2x |
| Forward P/S | 3.1x |
| P/B Ratio | 3.6x |
| P/TBV Ratio | 318.5x |
| P/FCF Ratio | 30.1x |
| P/OCF Ratio | 23.5x |
Enterprise Valuation
Counting debt and cash, the company is valued at 34.7x EBITDA and 30.3x free cash flow.
| EV / Earnings | 75.0x |
|---|---|
| EV / Sales | 3.2x |
| EV / EBITDA | 34.7x |
| EV / EBIT | 54.1x |
| EV / FCF | 30.3x |
Price Statistics
The stock is up 121.41% over 52 weeks and trades 10.27% above its 50-day average.
| Beta (1Y) | 0.85 |
|---|---|
| 52-Week Change | +121.41% |
| 1-Month Change | +20.39% |
| 3-Month Change | +10.44% |
| 6-Month Change | +83.31% |
| 5-Year Change | +11.85% |
| Total Return (1Y) | +121.41% |
| Total Return (3Y CAGR) | +31.93% |
| Total Return (5Y CAGR) | +10.08% |
| Return vs SPY (1Y) | +116.99% |
| Max Drawdown (1Y) | -17.06% |
| Max Drawdown (3Y) | -56.49% |
| Sharpe Ratio (1Y) | 1.90 |
| Correlation with SPY (1Y) | 0.27 |
| 50-Day Average | $12.85 |
| 200-Day Average | $9.75 |
| 52-Week Range | $6.05 to $15.66 |
| RSI (14 Days) | 59.2 |
| Average Volume (20 Days) | 6.87M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.44x current liabilities, and total debt is 0.17x shareholder equity.
| Current Ratio | 1.44x |
|---|---|
| Quick Ratio | 1.44x |
| Debt / Equity | 0.17x |
| Debt / EBITDA | 1.63x |
| Debt / FCF | 1.43x |
| Interest Coverage | 10.18x |
Returns and Efficiency
Return on invested capital is 4.57% over the last 12 months, against a 5-year average of -7.50%.
| Return on Equity (ROE) | 4.82% |
|---|---|
| Return on Assets (ROA) | 3.29% |
| Return on Invested Capital (ROIC) | 4.57% |
| Return on Capital Employed (ROCE) | 5.18% |
| ROE (5Y Average) | -10.09% |
| ROA (5Y Average) | -7.39% |
| ROIC (5Y Average) | -7.50% |
| Asset Turnover | 0.77x |
| Receivables Turnover | 14.46x |
Taxes
Income tax took 19.94% of pretax income over the last 12 months.
| Income Tax (TTM) | $17.91M |
|---|---|
| Effective Tax Rate | 19.94% |
Scores
LFST has an Altman Z-Score of 5.17, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.17 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $1.68B over the last 12 months.
| Revenue | $1.68B |
|---|---|
| Revenue Growth (YoY) | +22.62% |
| Gross Profit | $1.68B |
| Operating Income | $104.10M |
| Pretax Income | $89.82M |
| Net Income | $71.91M |
| EBITDA | $156.66M |
| EBIT | $99.71M |
| Reported EPS (TTM) | $0.28 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 68.04% of the $2.19B in total assets.
| Cash and Equivalents | $218.82M |
|---|---|
| Total Debt | $255.52M |
| Net Debt | $36.71M |
| Net Debt Per Share | $0.10 |
| Working Capital | $115.65M |
| Shareholder Equity | $1.49B |
| Book Value Per Share | $3.91 |
| Tangible Book Value | $16.96M |
| Tangible Book Per Share | $0.04 |
| Total Assets | $2.19B |
| Total Liabilities | $693.89M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $48.33M of capital spending, operating cash flow left $179.27M of free cash flow.
| Operating Cash Flow | $227.60M |
|---|---|
| Capital Expenditures | $48.33M |
| Free Cash Flow | $179.27M |
| FCF Per Share | $0.47 |
| Depreciation and Amortization | $56.95M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 6.21%, against a 5-year average of -17.22%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | 6.21% |
| Pretax Margin | 5.36% |
| Net Margin | 4.29% |
| EBITDA Margin | 9.34% |
| EBIT Margin | 5.95% |
| FCF Margin | 10.69% |
| Operating Margin (5Y Average) | -17.22% |
| Net Margin (5Y Average) | -18.53% |
Growth
Revenue grew 18.33% a year over 3 years.
| Revenue Growth (3Y CAGR) | +18.33% |
|---|---|
| Revenue Growth (5Y CAGR) | +30.44% |
| Book Value Per Share Growth (2Y CAGR) | +0.35% |
Dividends and Yields
LFST does not pay a dividend. Its free cash flow yield is 3.32%.
| Earnings Yield | 1.96% |
|---|---|
| FCF Yield | 3.32% |
| Buyback Yield | 2.27% |
| Shareholder Yield | 2.27% |
Peer Position
Against 12 similar companies, LFST has the 2nd highest P/E and the highest P/S.
P/E RatioPeer median 23.6x
P/S RatioPeer median 1.2x
ROICPeer median 12.96%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.68%
| P/E Ratio | 50.9x vs 23.6x median |
|---|---|
| P/S Ratio | 3.2x vs 1.2x median |
| ROIC | 4.57% vs 12.96% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +22.62% vs +8.68% median |
Analyst Forecast
Consensus estimates put revenue growth at 18.05% and EPS growth at 80.01% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +18.05% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +80.01% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LFST
What is LFST's market cap?
Lifestance Health Group has a market cap of $5.35B. Its enterprise value, which adds debt and subtracts cash, is $5.39B.
What is LFST's P/E ratio?
Lifestance Health Group has a trailing P/E ratio of 50.9x and a forward P/E of 80.9x.
How many shares of LFST are outstanding?
Lifestance Health Group has 381.21M shares outstanding. The count is down 1.49% from a year earlier.
Does LFST pay a dividend?
No. Lifestance Health Group does not pay a dividend.
How much debt does LFST have?
Lifestance Health Group has $255.52M of total debt and $218.82M of cash and equivalents, a net debt position of $36.71M.
LFST pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors